Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Molecular Medicine Reports
|
April 26, 2018
microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma
Yulin Lai, Liwen Zhao, Jia Hu, et al.
Frontiers in Oncology
|
September 22, 2022
OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis <i>via</i> regulating the arachidonic acid metabolism
Jie Wen, Abudureyimujiang Aili, Yao Xue Yan, et al.
Frontiers in Oncology
|
November 17, 2022
Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis <i>via</i> regulating the arachidonic acid metabolism
Jie Wen, Abudureyimujiang Aili, Yao Xue Yan, et al.
Molecular and Clinical Oncology
|
September 15, 2018
Primary adrenal teratoma: A case series and review of the literature
Liang Zhou, Xiang Pan, Tao He, et al.
Experimental and Therapeutic Medicine
|
March 28, 2018
Tumor suppressor miR-211-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma
Jing Quan, Xiang Pan, Tao He, et al.
Molecular Medicine Reports
|
March 22, 2024
[Retracted] Oncogenic miR-23a-5p is associated with cellular function in RCC
Jing Quan, Lu Jin, Xiang Pan, et al.
Molecular Medicine Reports
|
June 29, 2017
Oncogenic miR-23a-5p is associated with cellular function in RCC
Jing Quan, Lu Jin, Xiang Pan, et al.
Experimental and Therapeutic Medicine
|
June 14, 2018
miR-199b-5p serves as a tumor suppressor in renal cell carcinoma
Yulin Lai, Jing Quan, Canbin Lin, et al.
Experimental and Therapeutic Medicine
|
February 28, 2024
Erratum: [Corrigendum] miR‑199b‑5p serves as a tumor suppressor in renal cell carcinoma
Yulin Lai, Jing Quan, Canbin Lin, et al.
Experimental and Therapeutic Medicine
|
August 23, 2018
Erratum: miR-199b-5p serves as a tumor suppressor in renal cell carcinoma
Yulin Lai, Jing Quan, Canbin Lin, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Molecular Medicine Reports
|
April 26, 2018
microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma
Yulin Lai, Liwen Zhao, Jia Hu, et al.
Frontiers in Oncology
|
September 22, 2022
OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis <i>via</i> regulating the arachidonic acid metabolism
Jie Wen, Abudureyimujiang Aili, Yao Xue Yan, et al.
Frontiers in Oncology
|
November 17, 2022
Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis <i>via</i> regulating the arachidonic acid metabolism
Jie Wen, Abudureyimujiang Aili, Yao Xue Yan, et al.
Molecular and Clinical Oncology
|
September 15, 2018
Primary adrenal teratoma: A case series and review of the literature
Liang Zhou, Xiang Pan, Tao He, et al.
Experimental and Therapeutic Medicine
|
March 28, 2018
Tumor suppressor miR-211-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma
Jing Quan, Xiang Pan, Tao He, et al.
Molecular Medicine Reports
|
March 22, 2024
[Retracted] Oncogenic miR-23a-5p is associated with cellular function in RCC
Jing Quan, Lu Jin, Xiang Pan, et al.
Molecular Medicine Reports
|
June 29, 2017
Oncogenic miR-23a-5p is associated with cellular function in RCC
Jing Quan, Lu Jin, Xiang Pan, et al.
Experimental and Therapeutic Medicine
|
June 14, 2018
miR-199b-5p serves as a tumor suppressor in renal cell carcinoma
Yulin Lai, Jing Quan, Canbin Lin, et al.
Experimental and Therapeutic Medicine
|
February 28, 2024
Erratum: [Corrigendum] miR‑199b‑5p serves as a tumor suppressor in renal cell carcinoma
Yulin Lai, Jing Quan, Canbin Lin, et al.
Experimental and Therapeutic Medicine
|
August 23, 2018
Erratum: miR-199b-5p serves as a tumor suppressor in renal cell carcinoma
Yulin Lai, Jing Quan, Canbin Lin, et al.
Page
of 5